
Medpace Holdings MEDP
$ 596.05
-0.46%
Quarterly report 2025-Q3
added 10-23-2025
Medpace Holdings EV - Enterprise Value 2011-2025 | MEDP
Annual EV - Enterprise Value Medpace Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.8 B | 11.9 B | 7.96 B | 6.61 B | 5.04 B | 3.44 B | 2.63 B | 1.89 B | 1.56 B | 553 M | 695 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 11.9 B | 553 M | 4.83 B |
EV - Enterprise Value of other stocks in the Diagnostics research industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-19.1 M | $ 0.33 | -6.23 % | $ 30.6 M | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | $ 3.75 | 1.08 % | $ 308 M | ||
|
Global Cord Blood Corporation
CO
|
-2.77 B | $ 2.99 | - | $ 399 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | $ 21.99 | - | $ 562 M | ||
|
Genetron Holdings Limited
GTH
|
251 M | $ 4.03 | 0.12 % | $ 80.1 M | ||
|
Chembio Diagnostics
CEMI
|
39.2 M | $ 0.46 | 0.22 % | $ 16.8 M | ||
|
Meridian Bioscience
VIVO
|
1.27 B | $ 33.97 | - | $ 1.49 B | ||
|
HTG Molecular Diagnostics
HTGM
|
3.16 M | $ 0.48 | -20.0 % | $ 1.06 M | ||
|
Neogen Corporation
NEOG
|
2.26 B | $ 5.92 | -4.67 % | $ 1.28 B | ||
|
Quotient Limited
QTNT
|
393 M | $ 0.32 | -11.32 % | $ 1.1 M | ||
|
Pacific Biosciences of California
PACB
|
2.28 B | $ 1.85 | -3.4 % | $ 469 M | ||
|
Bioventus
BVS
|
904 M | $ 7.42 | 0.54 % | $ 465 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | $ 165.21 | - | $ 10.7 B | ||
|
Heska Corporation
HSKA
|
851 M | $ 119.99 | - | $ 1.31 B | ||
|
Motus GI Holdings
MOTS
|
568 K | $ 0.17 | -34.28 % | $ 263 K | ||
|
Biocept
BIOC
|
15 M | $ 0.43 | -13.05 % | $ 7.29 M | ||
|
Thermo Fisher Scientific
TMO
|
202 B | $ 565.62 | -0.38 % | $ 216 B | ||
|
Syneos Health
SYNH
|
14.1 B | $ 42.98 | - | $ 4.46 B | ||
|
Trinity Biotech plc
TRIB
|
133 M | $ 1.0 | 0.49 % | $ 61.9 M | ||
|
Invitae Corporation
NVTA
|
2.11 B | $ 0.09 | - | $ 21.2 M | ||
|
DermTech
DMTK
|
70.4 M | $ 0.09 | -11.32 % | $ 2.94 M | ||
|
Akumin
AKU
|
1.64 B | $ 0.29 | -17.87 % | $ 25.9 M | ||
|
Twist Bioscience Corporation
TWST
|
2.37 B | $ 30.2 | -4.19 % | $ 1.75 B | ||
|
Castle Biosciences
CSTL
|
665 M | $ 33.8 | 0.69 % | $ 939 M | ||
|
DarioHealth Corp.
DRIO
|
6.61 M | $ 12.58 | -7.4 % | $ 357 M | ||
|
PerkinElmer
PKI
|
17.7 B | $ 115.24 | -0.91 % | $ 14.7 B | ||
|
OpGen
OPGN
|
10.3 M | $ 1.96 | -16.95 % | $ 1.54 M | ||
|
DexCom
DXCM
|
52.4 B | $ 57.98 | -2.19 % | $ 22.4 B | ||
|
Organovo Holdings
ONVO
|
-4.05 M | $ 2.12 | -2.3 % | $ 19.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
433 M | $ 12.38 | 1.43 % | $ 132 M | ||
|
Koninklijke Philips N.V.
PHG
|
-2.4 B | $ 28.25 | 0.61 % | $ 20 B | ||
|
Danaher Corporation
DHR
|
150 B | $ 211.09 | -0.57 % | $ 154 B | ||
|
Biomerica
BMRA
|
6.63 M | $ 2.55 | -1.16 % | $ 5.86 M | ||
|
Fulgent Genetics
FLGT
|
502 M | $ 22.3 | -2.11 % | $ 674 M | ||
|
Psychemedics Corporation
PMD
|
20.5 M | $ 2.67 | -1.84 % | $ 15.3 M | ||
|
Genetic Technologies Limited
GENE
|
9.21 B | $ 0.77 | - | $ 7.1 B | ||
|
Renalytix AI plc
RNLX
|
33.9 M | $ 0.21 | 5.66 % | $ 22.7 M | ||
|
Myriad Genetics
MYGN
|
1.2 B | $ 6.32 | -4.03 % | $ 573 M | ||
|
Quidel Corporation
QDEL
|
460 M | $ 21.96 | -19.78 % | $ 925 M | ||
|
IQVIA Holdings
IQV
|
54.8 B | $ 211.48 | 0.67 % | $ 38.3 B | ||
|
Exagen
XGN
|
29 M | $ 10.74 | 3.97 % | $ 190 M | ||
|
CareDx, Inc
CDNA
|
644 M | $ 14.79 | -10.53 % | $ 795 M | ||
|
Brainsway Ltd.
BWAY
|
223 M | $ 15.74 | -2.69 % | $ 99.4 M | ||
|
Biodesix
BDSX
|
142 M | $ 8.28 | -3.78 % | $ 1.07 B | ||
|
T2 Biosystems
TTOO
|
54.9 M | $ 0.12 | -39.35 % | $ 313 K | ||
|
OPKO Health
OPK
|
1.62 B | $ 1.38 | 2.61 % | $ 958 M | ||
|
Guardant Health
GH
|
6.94 B | $ 96.79 | 1.83 % | $ 11.9 B | ||
|
Agilent Technologies
A
|
45.8 B | $ 147.11 | 0.22 % | $ 44.7 B | ||
|
Co-Diagnostics
CODX
|
29.3 M | $ 0.39 | -0.51 % | $ 11.4 M |